Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.76 |
| ▸ | MAPT | P10636 | 3/20 | 0.76 |
| ▸ | RECQL | P46063 | 3/20 | 0.76 |
| ▸ | TDP2 | O95551 | 2/20 | 0.76 |
| ▸ | NGF | P01138 | 1/20 | 0.76 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.76 |
| ▸ | BLM | P54132 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.60 |
| ▸ | USP2 | O75604 | 4/20 | 0.60 |
| ▸ | HTT | P42858 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.60 |
| ▸ | IDO1 | P14902 | 1/20 | 0.60 |
| ▸ | HAT1 | O14929 | 4/20 | 0.55 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CASP1 | P29466 | 2/20 | 0.55 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.55 |
| ▸ | CASP7 | P55210 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lumiflavin SCHEMBL193713 | 1.00 | MEN1 (0.76) | MEN1KMT2AMAPTRECQLTDP2 | |
| Lumiflavin SCHEMBL6365933 | 0.98 | MEN1 (0.74) | MEN1KMT2AMAPTRECQLTDP2 | |
| Lumiflavin SCHEMBL6373617 | 0.97 | MEN1 (0.72) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL864918 | 0.89 | MEN1 (0.69) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL9022677 | 0.89 | MEN1 (0.69) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL16557144 | 0.86 | MEN1 (0.66) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL15683182 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL10285873 | 0.86 | MEN1 (0.66) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL29375964 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL13955810 | 0.85 | MEN1 (0.61) | MEN1KMT2AMAPTRECQLTDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250042930-A1 | METHOD FOR PREPARING ARYL CARBON GLYCOSIDE COMPOUND INCLUDING GLIFLOZIN DRUG | SICHUAN UNIVERSITY (CN) | 2025-02-06 | — | — | US | disclosed |
| CN-118615596-A | Methods, devices and compositions for measuring and inducing intercellular communication and therapeutic uses thereof | 免疫之光有限责任公司 | 2024-09-10 | — | — | CN | disclosed |
| EP-2727607-B1 | Device and method for sterilization of instruments and surfaces | ROCK GAIL (CA) | 2024-07-24 | — | — | EP | disclosed |
| CN-113272011-B | Methods, devices and compositions for measuring and inducing intercellular communication and therapeutic uses thereof | 免疫之光有限责任公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20220409760-A1 | DEVICE AND METHOD FOR STERILIZATION OF INSTRUMENTS AND SURFACES | ROCK GAIL (CA) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042930-A1 | METHOD FOR PREPARING ARYL CARBON GLYCOSIDE COMPOUND INCLUDING GLIFLOZIN DRUG | UGGT1, GCG, SLC5A2 | MEN1 3827/4885KMT2A 1848/4885MAPT 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.